Center for Cellular Neurobiology and Neurodegeneration Research, Departments of Biological Sciences, Clinical Laboratory and Nutritional Sciences and Nursing, UMass Lowell, MA 01854, USA.
J Alzheimers Dis. 2012;30(1):27-33. doi: 10.3233/JAD-2012-112231.
Alzheimer's disease (AD) has no cure or nullifying pharmacological interventions. Nutritional supplementation represents a systemic approach that in some studies has provided benefit and has augmented pharmacological approaches. However, additional studies report no benefit of supplementation. We review herein how studies of nutrition on dementia, including those combining nutrition and dementia, are inherently compromised. We also review studies with mice, which demonstrate that nutritional supplementation can alleviate multiple genetic risk factors for AD. An individual diagnosed with AD has by definition undergone considerable cognitive decline; anticipating restoration/maintenance of cognitive performance following nutritional supplementation alone may be misdirected. Nutrition declines in aging, and even more so in AD. While optimization of nutrition should ideally be initiated well before any cognitive decline, we present evidence that the systemic benefit alone of nutritional supplementation at the very minimum warrants initiation along with pharmacological intervention.
阿尔茨海默病(AD)目前尚无治愈方法或能够中和其病理的药物干预手段。营养补充剂是一种全身性的治疗方法,一些研究表明其具有一定益处,并可增强药物治疗的效果。然而,也有研究并未发现补充剂的益处。本文回顾了关于营养与痴呆的研究,包括营养与痴呆相结合的研究,这些研究存在固有缺陷。我们还回顾了一些用老鼠进行的研究,这些研究表明,营养补充剂可以减轻 AD 的多种遗传风险因素。被诊断患有 AD 的患者已经经历了相当大的认知能力下降;仅仅通过营养补充剂来预期恢复/维持认知表现可能是错误的。随着年龄的增长,营养会下降,在 AD 患者中更是如此。虽然在认知能力下降之前,理想情况下应优化营养,但我们有证据表明,营养补充剂的全身性益处至少应与药物干预同时开始。